Clinical Trials Directory

Trials / Completed

CompletedNCT04431843

the Efficacy and Safety of Spirulina Maxima Extract on Improvement of Cognitive Function

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Spirulina Maxima Extract on Improvement of Cognitive Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study was the evaluate the efficacy and safety of Spirulina maxima extract on the improvement of Cognitive Function

Detailed description

This study was 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 80 subjects participated in Spirulina maxima extract or placebo group. To evaluate the changes in the evaluation items when Spirulina maxima extract was taken 12 weeks compared with placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSpirulina maxima extractonce a day for 2 p.o., after breakfast and dinner(1.52 g/day, Spirulina maxima extract for 1.5 g/day) for 12 week
DIETARY_SUPPLEMENTPlaceboonce a day for 2 p.o., after breakfast and dinner(1.52 g/day, Spirulina maxima extract for 0 g/day) for 12 week

Timeline

Start date
2020-03-17
Primary completion
2020-11-26
Completion
2020-11-26
First posted
2020-06-16
Last updated
2023-02-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04431843. Inclusion in this directory is not an endorsement.